| View Larger Image | Handbook of Coronary Stents | Hardcoverby Patrick W. Serruys (Editor), Benno J. Rensing (Editor)
| List Price: | $99.95 | | | Available: | Usually ships in 24 hours |
| | Binding: | Hardcover | | Publisher: | Informa Healthcare | | Edition: | 4th Edition | | Page Count: | 384 Pages | | Publication Date: | January 15, 2002 | | Sales Rank: | 1,682,126st |
|
EDITORIAL REVIEWS |
Product Description
Erasmus Univ., Rotterdam, The Netherlands. Handbook provides details of all the specifications of the currently available stents and illustrates each chapter with case studies and photographs of the stents themselves. Previous edition: c2000. |
CUSTOMER REVIEWS (Average Customer Rating: 5.0 based on 1 review)
|
Correct Information for This Edition by cortezhill (San Diego, CA)  5 Stars
January 01, 2006
Since 1986 when both Jacques Puel and Ulrich Sigart first inserted coronary stents into humans, tens of thousands of stents have been implanted. The coronary stent has become part of the basic armentarium of the interventional cardiologist. The question facing the interventional cardiologist is which stent would best serve the purpose? The Handbook of Coronary Stents has full technical details of 17 stents to help the operator. Patrick Serruys and the team at the Thoraxcentre have enlisted the help of stent designers and pioneers in stenting so that the reader is up-to-date with the latest stent designs. -- from book's back cover.
| |
SIMILAR PRODUCTS |
| Coronary Stenting: Current Perspectives
by Michael J B Kutryk (Author), Patrick W. Serruys (Author)
(Martin Dunitz) Academic Hospital RotterdamDijkzigt, The Netherlands. Discusses coronary stenting, why they are designed the way they are, what problems occur when implanting or retrieving them, and the results of clinical trials. For interventional cardiologists.
| 
| Handbook of Drug-Eluting Stents
by Patrick W. Serruys (Author), Anthony H. Gershlick (Author)
Over the past few years, the focus in interventional cardiology research has centered on reducing restenosis with the use of antiproliferative pharmacological agents. The use of these drugs, hitherto, has failed, most probably because of low active drug levels at the target site. This problem led to the development of local drug delivery using stents, since they can serve as a reservoir for local drug administration and are in immediate contract with the coronary artery wall, thus ensuring...
|
|
|
